Cranial Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Cranial Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The cranial implants market is expected to register a CAGR of nearly 5.6 % during the forecast period (2022-2027).

COVID-19 had affected the overall healthcare industry. Elective surgeries were massively delayed due to the sudden shutdown of a lot of healthcare services during the pandemic. As per the article published in 2021 under the title “Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation)”, all specialties have written guidelines for how to handle the pandemic, which has had a substantial impact on surgical practice. Every specialty had to prioritize the urgency of their routine surgical operations and, when practical, look into non-surgical care options. The Pandemic has affected workplace practices, surgical methods, open vs. minimally invasive procedures, theatre workflow, patient, and staff safety, as well as education and training. As per the point mentioned above, COVID-19 had a significant impact on the cranial implant market.

The major factors attributing to the growth of the cranial implants market are a rise in the number of brain tumors, an increased geriatric population, and enhanced public health awareness and measures that have led to rapid and effective medical interventions. For instance, as per Cancer.Net, brain and other nervous system cancer is the 10th leading cause of death for men and women. It is estimated that 18,280 adults in the United States (10,710 men and 7,570 women) were anticipated to be in a high-risk category for primary cancerous brain and CNS tumors in 2022. Worldwide, an estimated 251,329 people died from primary cancerous brain and CNS tumors in 2020.

Furthermore, the rise in government support, combined with increased research activities in technological advancements, fuels the cranial implants market. For instance, in 2021, the World Federation of Neurology announced its Brain Health Initiative, which intended to educate people regarding the importance of brain health. Education and advocacy through the initiative are likely to help people in the fight to improve brain health.

Hence as per the factors mentioned above, the cranial implant market is anticipated to witness growth over the forecast period. However, the high cost of cranioplasty and neurosurgical procedures may hamper the market growth.

Key Market TrendsCustomized Cranial Implants is Expected to Hold the Major Market Share in the Cranial Implants Market

The customized cranial implants are expected to account for the largest share of the cranial implants market in the forecasted period owing to their ability to meet the patient's specific needs by customizing the implants based on the injuries or defects, thereby reducing the risk of infection. There is also increasing approval of new products by the United States Food and Drug Administration that drives critical players to launch customized cranial implants with technological advancements in the market, which fuels the growth of the segment.

There are increased research and developments carried out in improving the customization for cranial implants, which boosts the market growth. For instance, the article published in 2022 under the title "Adaptive Mechanism for Designing a Personalized Cranial Implant and Its 3D Printing Using PEEK" stated that by using a newly developed hybrid technique, it is anticipated to be possible to create perfect cranial implants that are specific to each patient's problem. The implant is made of polyetheretherketone (PEEK), which is a suitable substitute for titanium implants for customized implants and is easier to use, lighter, and robust enough to protect the brain. Furthermore, the presence of competitors, mergers, acquisitions and new product launches fuels the market growth. For instance, in June 2022, OssDsign AB announced that the company has completed its first sales of OssDsign Cranial PSI in Japan. The launch marks an important strategic milestone, following a period of postponed commercial activities due to the Covid-19 pandemic. OssDsign Cranial PSI is a patient-specific cranial implant made from 3D printed medical-grade titanium covered by a regenerative calcium phosphate composition.

Due to the aforementioned factors, customized cranial implants are likely to witness growth over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America has been the primary market for cranial implants, owing to the rise in the number of brain tumor cases and an increase in the adoption of advanced technologies. For instance, as per the 2022 report from Cancer.net, approximately 5,900 brain and other CNS tumors are anticipated to be diagnosed in children ages 0 to 19 in the United States. After leukemia, brain and other CNS tumors are the second most common childhood cancers, accounting for about 26% of cancer in children younger than 15 and 21% of cancer in teens ages 15 to 19 in the United States.

Furthermore, the presence of competitors, product launches, and acquisitions boost the market studied in the North American region. For instance, in April 2021, the United States Food and Drug Administration (FDA) cleared a brain implant from Longeviti Neuro Solutions that enables clinicians to capture images of the brain after surgery. The Longeviti ClearFit implant is a neuro reconstructive implant that surgeons use to reconstruct a patient’s cranium.

As per the factors mentioned above North America is likely to face growth over the forecast period.

Competitive Landscape

The Cranial Implants Market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. Some of the companies which are currently dominating the market are B. Braun Melsungen AG, Johnson & Johnson, KLS Martin Group, Stryker Corporation, and Zimmer Biomet.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.